Oral Administration of ILacticaseibacillus rhamnosus/I CRL1505 Modulates Lung Innate Immune Response...
Oral Administration of ILacticaseibacillus rhamnosus/I CRL1505 Modulates Lung Innate Immune Response against IKlebsiella pneumoniae/I ST25
About this item
Full title
Author / Creator
Publisher
MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
MDPI AG
Subjects
More information
Scope and Contents
Contents
Orally administered Lacticaseibacillus rhamnosus CRL1505 enhances respiratory immunity, providing protection against respiratory viruses and Streptococcus pneumoniae. However, the capacity of the CRL1505 strain to improve respiratory immunity against Gram-negative bacterial infections has not been evaluated before. The aim of this work was to evalu...
Alternative Titles
Full title
Oral Administration of ILacticaseibacillus rhamnosus/I CRL1505 Modulates Lung Innate Immune Response against IKlebsiella pneumoniae/I ST25
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A750992854
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A750992854
Other Identifiers
ISSN
2076-2607
E-ISSN
2076-2607
DOI
10.3390/microorganisms11051148
